High materiality9/10
Eloxx Pharmaceuticals (ELOX) – Guggenheim initiates Buy; target 43
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim initiates Buy on Eloxx Pharmaceuticals; target 43; posted price 12.
- Guggenheim target 43; price 12 for Eloxx.
Key facts
- 01
Target: $43
- 02
Posted price: $12
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.